Back
Citizens Financial Services Vs. Novartis AG Industry Stock Comparison
Sell
43
CZFS
Citizens Financial Services
Last Price:
$58.10
Seasonality Move:
1.37%
Buy
71
NVSEF
Novartis AG
Last Price:
$116.60
Seasonality Move:
6.56%
Sell
43
Citizens Financial Services (CZFS)
is a Sell
Is Citizens Financial Services a Buy, Sell or Hold?
-
The current Citizens Financial Services [CZFS] share price is $58.09. The Score for CZFS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CZFS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CZFS Stock Price Chart
What is Citizens Financial Services's stock price today?
-
The Citizens Financial Services share price today is $58.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CZFS is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
CZFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.94 | Buy |
| Relative Strength Index (14 RSI): | 46.57 | Sell |
| Chaikin Money Flow: | -4836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.12 - 61.74) | Sell |
| Bollinger Bands (100): | (58.67 - 68.47) | Sell |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 61.26 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.1 - 113.78) | Buy |
| Bollinger Bands (100): | (98.55 - 109.41) | Buy |
CZFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.09 | Buy |
| 20-day SMA: | 58.62 | Sell |
| 50-day SMA: | 60.37 | Sell |
| 200-day SMA: | 56.87 | Buy |
| 8-day EMA: | 30.83 | Buy |
| 20-day EMA: | 15.12 | Buy |
| 50-day EMA: | 6.6 | Buy |
| 200-day EMA: | 1.72 | Buy |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.96 | Buy |
| 20-day SMA: | 111.23 | Buy |
| 50-day SMA: | 106.01 | Buy |
| 200-day SMA: | 106.77 | Buy |
| 8-day EMA: | 112.31 | Buy |
| 20-day EMA: | 110.66 | Buy |
| 50-day EMA: | 107.55 | Buy |
| 200-day EMA: | 104.74 | Buy |
Citizens Financial Services Earnings Growth & CZFS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.03 per share, an increase this year of $1.09 per share, and an increase next year of $0.35 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Citizens Financial Services Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||